Treatment with SD-282 at a low dose showed a trend toward reducing the inflammation but the difference was not significant.
← all excerpts
Selective p38α mitogen-activated protein kinase inhibitor attenuates lung inflammation and fibrosis in IL-13 transgenic mouse model of asthma.
1
—
—